NASDAQ:MRSN
Mersana Therapeutics, Inc. Stock News
$2.07
-0.150 (-6.76%)
At Close: Jun 14, 2024
Mersana Therapeutics, Inc. (MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unm
8 Overlooked REITs Beating The Crisis
11:45am, Wednesday, 13'th May 2020
We search for REITs with dislocations between price and fundamentals. These particular REITs are resilient through this environment making the cheap prices oppo
Daiichi Sankyo to Present New Research Data Across DXd ADC Portfolio at 2020 ASCO Annual Meeting
12:00am, Wednesday, 13'th May 2020
Daiichi Sankyo to present new research data across DXd ADC portfolio at 2020 ASCO Annual Meeting.